video1.0<iframe src="https://www.loom.com/embed/caef08fcc81f466ba4cb5212a6873cab" frameborder="0" width="1668" height="1251" webkitallowfullscreen mozallowfullscreen allowfullscreen></iframe>12511668Loomhttps://www.loom.com12511668https://cdn.loom.com/sessions/thumbnails/caef08fcc81f466ba4cb5212a6873cab-6724845e41f90a48.gif655.078In this video, I wanted to delve into the complexities of integrative oncology and the various testing options available. We discussed two advanced tests: the next-gen expression profiler and a chemo sensitivity report, which help identify effective treatments based on the genetic profile of a patient's tumor. These tests provide insights into over a thousand medications and can filter out ineffective options, guiding us towards more personalized treatment strategies. I encourage viewers to consider these testing options as we explore innovative approaches to enhance patient care. Please feel free to reach out with any questions or for further discussion on how these tests can be utilized effectively.